
Reset all filters
01 2Aspen Pharmacare Holdings
02 1Cohance Lifesciences
03 4Alfred E Tiefenbacher GmbH
04 2ANGITA PHARMA INC.
05 3Actavis Inc
06 2Adcock Ingram
07 5Alembic Pharmaceuticals Limited
08 4Alphapharm PTY Ltd
09 2Anchen Pharmaceutical, Inc
10 8Apotex Inc
11 4Arrow Pharmaceuticals
12 2Ascent Innovative Medicines
13 2Aspire Lifesciences Pvt Ltd
14 2Cipla Medpro South Africa
15 2Eurofarma Laboratorios S.A
16 4Generic Health
17 3Hikma Pharmaceuticals
18 2INNOVATA PHARMACEUTICALS
19 2JAMP PHARMA
20 1Jivita Health Care
21 3Lupin Ltd
22 2MEDICAP LABS
23 2Macleods Pharmaceuticals Limited
24 2NORVIUM BIOSCIENCE
25 1Noucor
26 2Osmotica Pharmaceuticals
27 2PRO DOC LIMITEE
28 4Pfizer Consumer Healthcare
29 7Pfizer Inc
30 2Pharma Dynamics
31 2Precise Group
32 3Rubicon Research
33 2SANIS HEALTH INC
34 10Sandoz B2B
35 2Taro Pharmaceutical Industries
36 2Teva Pharmaceutical Industries
37 4WAGNER PHARMACEUTICALS PTY LTD
38 5Yichang Humanwell Pharmaceutical
39 3Zydus Pharmaceuticals
40 6Blank
Reset all filters
01 4Coated Tablet
02 3ER Tablet
03 2Extended Release Tablet
04 4Extended-Release Tablet
05 2FCT
06 2Granules
07 4Prolonged Release tablet
08 1Sustain Release Pellet
09 1Sustained Release Tablet
10 10TAB
11 20TABLET (EXTENDED-RELEASE)
12 36TABLET, EXTENDED RELEASE;ORAL
13 2Tablet
14 32Blank
Reset all filters
01 4DISCN
02 4EU Dossier Readiness-Q1 2020
03 12Generic
04 2Originator
05 20Prescription
06 30RX
07 51Blank
Reset all filters
01 128 Enzude 100Mg Extended Release Tablets
02 128 Enzude 50Mg Extended Release Tablets
03 2AG-DESVENLAFAXINE
04 2APO-DESVENLAFAXINE
05 2APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS
06 4APO-Desvenlafaxine MR
07 4BTC Desvenlafaxine
08 4DESVEN
09 8DESVENLAFAXINE
10 27DESVENLAFAXINE SUCCINATE
11 4DESVENLAFAXINE-WGR XR
12 1Depven 100 XL
13 1Depven 50 XL
14 4Desfax
15 2Deslafeks
16 1Deslafore XR 100
17 1Deslafore XR 50
18 4Desvenlafaxine GH XR
19 4Desvenlafaxine Sandoz
20 1Exlov XR 100 mg
21 1Exlov XR 50 mg
22 1Exsira 100mg
23 1Exsira 50mg
24 2JAMP DESVENLAFAXINE
25 2KHEDEZLA
26 5PRISTIQ
27 4Pristiq
28 1Pristiq 100Mg Extended Release Tablets 28
29 1Pristiq 50Mg Extended Release Tablets 28
30 2SANDOZ DESVENLAFAXINE
31 2TARO-DESVENLAFAXINE
32 2TEVA-DESVENLAFAXINE
33 1Voloxin 100mg
34 1Voloxin 50mg
35 19Blank
Reset all filters
01 32Australia
02 4Brazil
03 20Canada
04 2China
05 4Germany
06 8India
07 12South Africa
08 5Spain
09 36USA
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Voloxin 50mg
Dosage Form : TAB
Dosage Strength : 50mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Pellet
Dosage Strength : 41.38%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Voloxin 100mg
Dosage Form : TAB
Dosage Strength : 100mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2016-07-29
Application Number : 204065
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2016-07-29
Application Number : 204065
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2016-07-29
Application Number : 204065
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2018-09-14
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2013-03-04
Application Number : 204150
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 204009
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 204009
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2016-02-16
Application Number : 204082
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2017-08-28
Application Number : 204082
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2016-02-16
Application Number : 204083
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2008-02-29
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2008-02-29
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2014-08-20
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2023-12-07
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2017-10-11
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2017-10-11
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2022-11-30
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204095
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204095
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF